Impact BioMedical Inc.

AMEX: IBO · Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-1.77%
After-hours: Aug 15, 2025, 06:43 PM EDT

Impact BioMedical Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 428.33K 469.6K 469.6K 600.8K 541.59K 933.48K 1.07M 939.6K 570.48K 137.32K n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 67.52K 67.52K 67.52K 67.52K n/a n/a
Gross Profit
n/a n/a n/a n/a n/a 428.33K 469.6K 469.6K 600.8K 541.59K 933.48K 1M 872.08K 502.96K 69.8K n/a n/a
Operating Income
-28.99M -28.75M -3.66M -2.54M -1.91M -1.07M -79.67K -242.04K -284.48K -182.67K 263.51K -1.11M -1.08M -1.19M -1.49M 78.43K 135.85K
Interest Income
12K 12K 12K 9K 6K 3K n/a n/a n/a n/a n/a n/a n/a n/a n/a 25.00 25.00
Pretax Income
-25.02M -24.74M 1.1M -3.14M -2.26M -1.75M -1.28M -2.12M -8.67M -9.36M -9.61M -10.5M -3.97M -2.88M -1.92M -259.25K -290.65K
Net Income
-25.02M -24.71M 1.16M -3.09M -2.2M -1.72M -1.28M -2.12M -8.67M -9.36M -9.61M -10.5M -3.97M -2.88M -1.92M -259.25K -290.65K
Selling & General & Admin
2.15M 1.95M 1.63M 914.59K 580.2K 689.95K 1.01M 1.56M 2.39M 3.09M 3.57M 4.57M 3.76M 2.66M 1.63M 90.12K 77.11K
Research & Development
77K 157K 728K 1.13M 1.48M 1.3M 837.27K 361.59K 132.13K 262.05K 418.52K 409.31K 286.39K 156.47K n/a n/a n/a
Other Expenses
26.76M 26.65M 1.3M 491.98K -150.67K -433.67K -835.67K -351.65K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
28.99M 28.75M 3.66M 2.54M 1.91M 1.99M 1.7M 2.49M 3.69M 4.36M 4.94M 5.75M 4.57M 3.06M 1.68M 90.42K 77.41K
Interest Expense
1.11M 1.07M 921K 616K 355K 179.89K 91.33K 138.04K 150.06K 105.36K 90.53K 67.74K 55.72K 45.52K 23.92K n/a n/a
Selling & Marketing Expenses
644K 633K 620K 159.02K 141.04K 133.04K 36.34 13.25 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
28.99M 28.75M 3.66M 2.54M 1.91M 1.99M 1.7M 2.49M 3.69M 4.36M 4.94M 5.82M 4.63M 3.13M 1.74M 90.42K 77.41K
Income Tax Expense
33K 33K n/a n/a n/a 54.89K 91.33K 138.04K 22.51K -22.18K -37.01K -59.8K 58.03K 119.69K 142.38K 168.83K 213.24K
Shares Outstanding (Basic)
12.06M 11.51M 72M 11.5M 11.5M 26.07M 58.1K 55.1K 191.49M 191.49M 190.76M 188.2M 190.74M 190.68M 170.55M 11M 9.65M
Shares Outstanding (Diluted)
12.06M 11.51M 72M 11.5M 11.5M 29.5M 70.5K 70.5K 191.49M 191.49M 190.76M 188.2M 190.74M 190.68M 170.55M 11M 9.65M
EPS (Basic)
-3.39K -3.39K -55.29 -55.68 -55.63 -55.55 -0.05 -0.03 -0.05 -0.05 -0.05 -0.06 -0.02 -0.03 -0.03 -0.03 -0.03
EPS (Diluted)
-3.39K -3.39K -62.9 -62.99 -62.94 -62.86 -0.06 -0.04 -0.05 -0.05 -0.05 -0.06 -0.02 -0.03 -0.03 -0.03 -0.03
EBITDA
-22.79M -22.56M 3.14M -1.69M -1.35M -1.21M -1.09M -1.81M -2.93M -3.66M -3.85M -4.61M -3.51M -2.37M -1.44M 78.73K 136.15K
EBIT
-23.91M -23.68M 2.02M -2.53M -1.91M -1.14M -2.8K -1.33K n/a n/a n/a -1.54M -1.55M -1.49M -1.49M 78.43K 135.85K
Depreciation & Amortization
1.12M 1.12M 1.12M 839K 560K 352.31K 141.74K 208.07K 287.24K 286.49K 286.01K 266.4K 187.31K 115.82K 46.95K 306.00 305.00